Price $215.31 |
Market Cap
30.51B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
53.4
|
P/B
8.2
|
P/S
15.25
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
33.3
|
Op. Cash Flow
977K
|
FCF
5.8
|
|
Op. Margin
17.70%
|
Net Margin
24.20%
|
ROE
14.20%
|
ROI
11.80%
|
|
ROA
11.20%
|
EPS Growth
31.70%
|
Current Ratio
3.9
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc (INM) | $0.27 | - | - | 1.6M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $15.72 | - | - | 1.19B | Strong Buy |
| PetIQ Inc (PETQ) | $30.58 | - | - | 564.3M | Strong Buy |
| Pharmacyte Biotech Inc (PMCB) | $1.65 | - | - | 18.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
